-4.7%
MRNA vs GLDM
+107.2%
-111.8%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GLDM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.1% | -3.6% | -3.6% |
| 7D | -12.1% | -4.6% | -7.5% | -8.4% |
| 30D | -1.3% | -5.5% | +4.2% | +4.1% |
| 3M | +250.9% | -10.9% | +261.8% | +293.3% |
| 6M | +343.0% | -17.3% | +360.3% | +409.2% |
| YTD | +657.4% | -10.2% | +667.6% | +756.9% |
| 1Y | +794.9% | -6.9% | +801.9% | +902.2% |
| 3Y | +218.1% | +98.7% | +119.5% | +190.1% |
| All | -4.7% | +107.2% | -111.8% | -24.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GLDM.
Daily Out/Under-Performance
Portfolio return minus GLDM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLDM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GLDM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling